Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 30.74
+0.38 (1.25%)
Sep 30, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 11.31 billion as of September 29, 2026. Its market cap has decreased by -59.05% in one year.
Market Cap
11.31B
Enterprise Value
11.55B
Revenue
741.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.74
ChartMarket Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 11.31B, an increase of 49.02%. That is a compound annual growth rate of 5.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 11.31B | -41.20% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HBM Holdings | 11.38B |
| GenFleet Therapeutics (Shanghai) | 11.07B |
| Nanjing Leads Biolabs | 10.20B |
| Everest Medicines | 9.74B |
| Ascletis Pharma | 9.04B |
| Suzhou Ribo Life Science | 8.92B |
| CStone Pharmaceuticals | 8.50B |
| LongBio Pharma (Suzhou) | 8.42B |